search button

MEDROXYPROGESTERONE ACETATE (MPA) INCREASES PAI-1 SECRETION FROM HUVEC AND ELEVATES THE PLASMA-LEVELS OF PAI-I IN-VIVO

  • Authors:
    • K SERIZAWA
    • T URANO
    • Y KOJIMA
    • H IHARA
    • Y TAKADA
    • S TAKEUCHI
    • A TAKADA

  • View Affiliations

  • Published online on: November 1, 1994     https://doi.org/10.3892/or.1.6.1127
  • Pages: 1127-1130
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Plasma levels of tissue type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in patients administered with medroxyprogesterone acetate (MPA) (800 mg/day) or tamoxifen (20 mg/day) were assayed. Active free PAI-1 levels of patients given MPA were significantly higher than those either given tamoxifen or post adjuvant therapy, t-PA antigen levels were not different among the three groups. In in vitro study, treatment of cultured human umbilical vein endothelial cells (HUVEC) with MPA (10(-6)-10(-8) M) decreased PAI-1 levels significantly with a trend to decrease in t-PA levels.

Related Articles

Journal Cover

November 1994
Volume 1 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.8
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.5
  • CiteScore Rank: Q1: #74/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.719
  • SCImago Journal Rank (SJR): 0.864
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
SERIZAWA K, URANO T, KOJIMA Y, IHARA H, TAKADA Y, TAKEUCHI S and TAKADA A: MEDROXYPROGESTERONE ACETATE (MPA) INCREASES PAI-1 SECRETION FROM HUVEC AND ELEVATES THE PLASMA-LEVELS OF PAI-I IN-VIVO. Oncol Rep 1: 1127-1130, 1994.
APA
SERIZAWA, K., URANO, T., KOJIMA, Y., IHARA, H., TAKADA, Y., TAKEUCHI, S., & TAKADA, A. (1994). MEDROXYPROGESTERONE ACETATE (MPA) INCREASES PAI-1 SECRETION FROM HUVEC AND ELEVATES THE PLASMA-LEVELS OF PAI-I IN-VIVO. Oncology Reports, 1, 1127-1130. https://doi.org/10.3892/or.1.6.1127
MLA
SERIZAWA, K., URANO, T., KOJIMA, Y., IHARA, H., TAKADA, Y., TAKEUCHI, S., TAKADA, A."MEDROXYPROGESTERONE ACETATE (MPA) INCREASES PAI-1 SECRETION FROM HUVEC AND ELEVATES THE PLASMA-LEVELS OF PAI-I IN-VIVO". Oncology Reports 1.6 (1994): 1127-1130.
Chicago
SERIZAWA, K., URANO, T., KOJIMA, Y., IHARA, H., TAKADA, Y., TAKEUCHI, S., TAKADA, A."MEDROXYPROGESTERONE ACETATE (MPA) INCREASES PAI-1 SECRETION FROM HUVEC AND ELEVATES THE PLASMA-LEVELS OF PAI-I IN-VIVO". Oncology Reports 1, no. 6 (1994): 1127-1130. https://doi.org/10.3892/or.1.6.1127